🔎 Trials Near Me

Gara Jalqabaatti › Kansaarii Servikaalii › Massachusetts › Boston

Qorannoo klinikaalii Kansaarii Servikaalii Boston, MA keessatti

Qorannoo 18 Kansaarii Servikaalii f Boston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Distance-Based Exercise to Preserve Function and Prevent Disability

Namoota walitti qabaa jira
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07059884

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Massachusetts General Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06465069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Namoota walitti qabaa jiraSadarkaa 2
  • Dana-Farber Cancer Institute - Oncology Department, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06760819

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Namoota walitti qabaa jiraSadarkaa 1/2
  • Tufts Medical Center, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06047379

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT05983432

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Namoota walitti qabaa jiraSadarkaa 1/2
  • Massachusetts General Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07109726

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT06293898

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • Mass General Cancer Center, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT07227168

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Normunity Investigational Site, Boston
  • Normunity Investigational Site, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT07182149

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Massachusetts General Hospital Cancer Center, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT05592626

Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice, RCT

Namoota walitti qabaa jira
  • Massachusetts General Brigham, Boston
Umuriin 21 hanga 70 · Dubartoota · Haaromfame 07-Hag-2026 · NCT06872346

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT05768139

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Massachusetts General Hospital, Boston
  • Brigham & Women's Hospital, Boston
  • Beth Israel Deaconess Medical Center,East Campus Research Pharmacy, Boston
  • fi 2 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT04389632

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Beth Israel Deaconess Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT06993844

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Massachusetts General Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT06239194

Building Connections

Namoota walitti qabaa jira
  • Disparities Research Unit, Massachusetts General Hospital, Boston
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 18-Sad-2025 · NCT07091032

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

Namoota walitti qabaa jiraSadarkaa 2
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Dubartoota · Haaromfame 05-Sad-2025 · NCT06677190

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2025 · NCT05941507

Qorannoo Kansaarii Servikaalii magaalota biroo keessatti

Qorannoo biroo Boston keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.